ASKA Eyes 33% Rise in Women’s Health Sales by FY2020

January 5, 2017
Hirokuni Teramoto, Head of Sales Division, ASKA ASKA Pharmaceutical is revving up its drive to enrich its women’s health portfolios, looking to pull in sales of 10 billion yen from these products in FY2020, up around 33% from the current...read more